Cardiovascular Flashcards
How do you assess direction of polarisation and axis deviation on an ECG
R wave shows direction of polarisation, should increase V1-4 (S waves increase V1-3 then decrease)
Axis should be directed towards lead II (most positive deflection)
Left axis Leaves II and III (I only positive, aVF negative), Right axis Returns to II and III (I only negative, aVF positive)
Describe the depolarisation of heart cells
HEART CELL DEPOLARISATION: SLOW ENTRY OF SODIUM IONS TO CAUSE MEMBRANE POTENTIAL TO RISE FROM -60 TO -40mV, SPONTANEOUS DEPOLARISATION, CALCIUM ENTER CAUSING STRONGER DEPOLARISATION TO +5mV, POTASSIUM CAUSES REPOLARISATION BACK TO -60mV (CALCIUM AND POTASSIUM CHANNELS CLOSE)
What parts of the clotting process do different anticoagulants affect
(Platelet aggregation)
Aspirin inhibits COX-1 and therefore thromboxane A2, less activation and aggregation
P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor), reduce ADP, less activation and aggregation
(Coagulation cascade)
Warfarin inhibits vitamin K - reduces II, VII, IX, X
Heparins increase antithrombin, inactivates thrombin and Xa, thrombin means less conversion of fibrinogen
DOACs: majority direct and reversible inhibitors of Xa, dabigatran inhibits thrombin
Decsribe CHA2DS2VASc
CHA2DS2VASc (stroke assessment): =2 anticoagulant (=1 for men consider)
Chronic HF, hypertension, age >75 - 2, diabetes, stroke / TIA - 2, vascular disease, age 65-75, sex category female
2 = 2% stroke risk per year
Describe the presentation of angina / IHD
Chest pain - tight, stab/ belt/ heavy, middle of chest
May radiate to one or both arms, neck, jaw, teeth
Breathless, palpitations, presyncope (sensation you are going to faint)
Very exercise related
How is IHD diagnosed and what investigations are used
Diagnosis usually entirely from history
Primary care: ECG, haemoglobin, lipid profile, glucose / HbA1c
CT coronary angiogram gold standard, contrast used, assess flow of coronary arteries
Determine if obstructive coronary artery disease. If left main stem or severe 3 vessel disease → coronary angiography
ECG - usually normal, may show ST depression, flat/ inverted T waves
Cardiac stress test (exercise or dobutamine), monitor with ECG, ST depression = late stage. Many patients unsuitable
Describe the ECG changes in acute coronary syndrome
STEMI: ST elevation and new left bundle branch block (wide QRS, V1-6), hyperactive T waves, pathological Q waves
NSTEMI: ST depression and T wave inversion
Pathological Q waves present after 6h of symptoms in full thickness infarction
Specific arteries: left coronary - anterolateral (I, aVL, V3-6); LAD - anterior (V1-4); circumflex - lateral (I, aVL, V5-6); right coronary - inferior (II, III, aVF)
Unstable angina usually has normal ECG
Describe the management of angina / IHD
Lifestyle advice
All patients aspirin (clopidogrel if contraindicated) and a statin, dual therapy with aspirin + clopidogrel / rivaroxaban in patients ACS or undergoing PCI
If required also antihypertensives (target 120-130) - ACE / BB / ARB; antidiabetic drugs
Symptom relief: GTN spray, beta blocker, calcium channel blocker, long acting nitrate
Surgery when medical not working, PCI and CABG
Why are antiplatelets the main stay of treatment in acute coronary sundrome
When a thrombus forms in a fast flowing artery it is mainly formed by platelets
What is the presentation of ACS
Acute chest pain lasting longer than 20 mins, at rest, ⅓ in bed at night
Can radiate to left arm, jaw, neck. Does not respond to GTN
Sweating, nausea, vomiting, breathless, palpitations, anxiety, sense of impending doom
Significant hypotension. brady/ tachycardia
Describe the investigations for ACS
Immediate ECG, coronary angiography (within 12h)
Bloods: troponin, glucose, FBC, U+Es, (CRP + lipids)
How is a STEMI acutely managed
300mg aspirin + prasugrel / clopidogrel, IV morphine, ondansetron (add O2 and IV GTN if required)
Assess if PCI suitable - within 12h of onset / 2h of when fibrinlysis could be given without contraindications (IV unfractioned heparin in surgery)
Otherwise thrombolysis with alteplase / tenecteplase
How is risk of NSTEMI assessed
GRACE score: age, HR, systolic, creatinine, cardiac arrest at admission, ST deviation, abnormal cardiac enzymes, killip class (no CHF, rales / JVD, pulmonary oedema, cardiogenic shock)
How are NSTEMIs acutely managed
Grace score
High risk: coronary angiography +- revascularisation, 300mg aspirin + prasugrel / clopidogrel. If required: O2, morphine, GTN, ondansetron, heparin (fondaparinux)
Low risk: same as above but surgery not required if 6m mortality below 3%
How are patients managed following an MI
Echocardiogram to assess LV function, cardiac rehabilitation (lifestyle)
Secondary prevention - continue dual antiplatelet, ACE inhibitors / ARB, beta blockers / rate limiting CCB, statins. If HF: spironolactone + dapgliflozin
Define heart failure
Heart failure is caused by a structural and/or functional abnormality that produces raised intracardiac pressures and/or inadequate cardiac output at rest and/or at exercise
Describe the pathophysiology of heart failure
When drop in arterial pressure in aorta/ heart, baroreceptors activate sympathetic nervous system. In heart failure there is chronic activation, effect is diminished, cardiac output stops increasing
Impaired LV function leads to backlog of blood, LA / pulmonary veins have increased volume + pressure, fluid leaks out
How do you investigate heart failure (what do they show)
Transthoracic echocardiogram, ECG, CXR, NT BNP blood test; also: troponin, FBC, U+Es, HbA1c, LFTs, TFTs, CRP
Exercise stress testing, (CT) coronary angiogram
NT-proBNP blood test increased, echocardiogram - chamber size, valvular disease, MI
<400pg/mL HF unlikely, 400-2000 transthoracic doppler + specialist within 6 weeks, >2000 within 2 weeks + poor prognosis
X ray (ABCDE): Alveolar oedema (batwing), Kerley B lines (horizontal - peripheral lungs), Cardiomegaly, Dilated upper lobe vessels, pleural Effusion (costophrenic blunting)
ECG - ischaemia, MI, LV hypertrophy
How is heart failure classified
NYHA Classification: I - no limitation (asymptomatic), II - slight limitation, III - marked limitation (symptoms on minimal exertion), IV - inability to carry out physical activity
How is heart failure managed
Treat cause, lifestyle (avoid large meals (workload, sodium - water retention), vaccination)
Management ABAL: ramipril (ACE) (evidence sacubitril / valsartan better), bisoprolol (BB), spironolactone (aldosterone antagonist), furosemide (loop)
Symptoms persist - specialist: amiodarone, digoxin, sacubitril + valsartan
Avoid ACE if valve pathology
Calcium channel blockers and dihydropyridines (nifedipine) avoided in reduced
Comprehensive therapy (abs vp): aldosterone antagonist + beta blocker + sacubitril-valsartan + dapagliflozin (SGLT2 inhibitor)
Preserved ejection fraction (specialist): dapagliflozin, furosemide if still fluid overload
What are the causes of secondary hypertension
ROPED: renal disease, obesity, pregnancy induced / preeclampsia, endocrine, drugs
Most common causes: renal (CKD, renal artery stenosis, nephritis), sleep apnoea, coarctation of aorta
How is hypertension managed including different demographics
ACD pathway - ACE inhibitor (or ARB), calcium channel blocker, diuretics (thiazides then loop)
Ramipril (candesartan), nifedipine, bendroflumethiazide (furosemide)
Beta blockers are not first line but consider in young people
If 55+ or Afro-Caribbean likely low renin, calcium channel blocker first and ARB instead of ACE
In diabetics: ACD no matter the age
What causes supraventricular tachycardia and how does it present on ECG
Electrical signal reneters the atria from the ventricles, causes another depolarisation and repeats
Presents with narrow complex tachycardia (< 0.12s or 3 small squares) followed immediately by T wave, P waves usually buried by T waves. HR > 150
How do atrial flutter, AV block and L / R BBB present on ECG
Atrial flutter - organised sawtooth waves, regular QRS, two P waves for every QRS
AV block - long PR, 1st - PR and QRS associated, 2nd slightly associated (Mobitz I PR progressively prolonged until dropped, II PR constant but not always followed by QRS), 3rd no association between P and QRS
Left bundle branch block (wiLLiam) - ‘w’ shape in V1 + ‘m’ shape in V6, broad QRS, prolonged / broad R wave in V5/6, dominant S wave in V1, absence of Q waves in lateral leads
Right bundle branch block (moRRow) - ‘m’ shape in V1 + ‘w’ shape in V6, broad QRS, slurred S waves in lateral leads
How do you manage tachycardias
Tachycardia: beta blockers and calcium channel blockers. AV node reentry tachycardia most common - catheter ablation. If systolic < 90 - DC cardioversion
Supraventricular T: adenosine, verapamil (can’t be given with BB)
Broad complex: IV amiodarone, DC cardioversion (haemodynamically unstable)
How is AF investigated
ECG: irregularly irregular, absent P waves, narrow QRS
Echo to see if structural
Bloods: FBC, U+Es, TFTs, LFTs, clotting profile
Also CHADSVasc and ORBIT
How is AF managed
Acute: haemodynamically unstable - electrically cardioverted, stable and <48h rate / rhythm, >48h rate control
Rate or rhythm: rate control FL unless: AF reversible, new onset within 48h, HF caused by AF.
Rate (ventricular): beta blocker (atenolol) or rate limiting CCB (verapamil, diltiazem) (avoid in HF), digoxin if unsuitable, dual therapy
Rhythm (sinus): cardioversion + long term rhythm control, beta blocker FL, dronedarone SL (or amiodarone (LV impairment / HF), consider left atrial ablation
Cardioversion is immediate if <48h or haemodynamically unstable; electrical (defib under sedation), pharmacological - flecainide, amiodarone
Both ineffective or not tolerated: LA ablation, AV node ablation + pacemaker
DOAC for clots, warfarin if DOAC contraindicated, both contraindicated - consider left atrial appendage occlusion